| Code | 7180A | ||||||||||
| MA number | EU/1/13/860/001 | ||||||||||
| Product Form: | tbl ent 7x20 mg (blis.Al/Al) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | GlaxoSmithKline Dungarvan Ltd., Ireland | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 26.08.2013 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | No |
| Data update: | 05.11.2018 |
